| LpMab-12 Established by CasMab Technology Specifically Detects Sialylated O-glycan on Thr52 of Platelet Aggregation-stimulating Domain of Human Podoplanin
| [0007]
|
| The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activity
| [0007]
|
| A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin
| [0007]
|
| Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity
| [0007]
|
| PNAS
| [0038]
[0079]
|
| J. Mol. Bio.
| [0038]
[0079]
|
| J. Mol. Biol.
| [0038]
[0079]
|
| J. Mol. Biol.
| [0038]
[0079]
|
| Nat. Biotechnol.
| [0080]
|
| Jpn. J. Cancer Res.
| [0080]
|
| J. Mol. Biol.
| [0080]
|